Predicting Binding Affinity of Some Imatinib Derivatives as BCR-ABL Tyrosine Kinase Inhibitors Based on Monte Carlo Optimization
Introduction: The Imatinib drug is used to treat blood cancer by inhibiting the BCR-ABL tyrosine kinase enzyme, which prevents the proliferation of cancer cells. Materials & Methods: In order to predict the binding affinity of 555 compounds of imatinib derivatives as ABL-BCR tyrosine kinase inh...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Ilam University of Medical Sciences
2024-09-01
|
| Series: | Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām |
| Subjects: | |
| Online Access: | http://sjimu.medilam.ac.ir/article-1-8190-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|